This result indicated that the therapeutic effect of melatonin in COPD is associated with the suppression of PDE4, and when combined with the PDE4 inhibitor, its therapeutic effect in COPD is greatly elevated. Here, PDE4A is linked to chronic obstructive pulmonary disease.